These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 30223270)
1. Differential Expression of Cancer-Associated Fibroblast-Related Proteins in Ductal Carcinoma in situ According to Molecular Subtype and Stromal Histology. Lee JH; Kim HM; Koo JS Pathobiology; 2018; 85(5-6):311-321. PubMed ID: 30223270 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Park SY; Kim HM; Koo JS Breast Cancer Res Treat; 2015 Feb; 149(3):727-41. PubMed ID: 25667103 [TBL] [Abstract][Full Text] [Related]
3. Expression of cancer-associated fibroblast-related proteins in adipose stroma of breast cancer. Jung YY; Lee YK; Koo JS Tumour Biol; 2015 Nov; 36(11):8685-95. PubMed ID: 26044562 [TBL] [Abstract][Full Text] [Related]
4. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma. Park CK; Jung WH; Koo JS Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595 [TBL] [Abstract][Full Text] [Related]
5. Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis. Kim HM; Jung WH; Koo JS J Transl Med; 2015 Jul; 13():222. PubMed ID: 26163388 [TBL] [Abstract][Full Text] [Related]
6. Glucose and glutamine metabolism-related protein expression in breast ductal carcinoma in situ. Ryu HJ; Koo JS Neoplasma; 2022 May; 69(3):630-639. PubMed ID: 35263998 [TBL] [Abstract][Full Text] [Related]
7. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Tsutsumi Y Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930 [TBL] [Abstract][Full Text] [Related]
8. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence. Han K; Nofech-Mozes S; Narod S; Hanna W; Vesprini D; Saskin R; Taylor C; Kong I; Paszat L; Rakovitch E Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):183-9. PubMed ID: 21958729 [TBL] [Abstract][Full Text] [Related]
9. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status. Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722 [TBL] [Abstract][Full Text] [Related]
10. Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma. Sun WY; Jung WH; Koo JS Tumour Biol; 2016 Jun; 37(6):8197-207. PubMed ID: 26715280 [TBL] [Abstract][Full Text] [Related]
11. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Steinman S; Wang J; Bourne P; Yang Q; Tang P Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367 [TBL] [Abstract][Full Text] [Related]
12. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast. Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076 [TBL] [Abstract][Full Text] [Related]
13. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events. Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214 [TBL] [Abstract][Full Text] [Related]
14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
15. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component. Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India. Doval DC; Sharma A; Sinha R; Kumar K; Dewan AK; Chaturvedi H; Batra U; Talwar V; Gupta SK; Singh S; Bhole V; Mehta A Asian Pac J Cancer Prev; 2015; 16(12):4959-64. PubMed ID: 26163622 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer. Sun WY; Choi J; Cha YJ; Koo JS Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29261141 [TBL] [Abstract][Full Text] [Related]
18. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ. Strell C; Paulsson J; Jin SB; Tobin NP; Mezheyeuski A; Roswall P; Mutgan C; Mitsios N; Johansson H; Wickberg SM; Svedlund J; Nilsson M; Hall P; Mulder J; Radisky DC; Pietras K; Bergh J; Lendahl U; Wärnberg F; Östman A J Natl Cancer Inst; 2019 Sep; 111(9):983-995. PubMed ID: 30816935 [TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in ductal carcinoma in situ (DCIS) and DCIS with microinvasion. Wan ZB; Gao HY; Wei L; Zhang AQ; Zhang JY; Wang Y; Wang DD; Zhang Y Medicine (Baltimore); 2018 Nov; 97(44):e13055. PubMed ID: 30383678 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes. Cid S; Eiro N; Fernández B; Sánchez R; Andicoechea A; Fernández-Muñiz PI; González LO; Vizoso FJ Clin Breast Cancer; 2018 Feb; 18(1):e123-e133. PubMed ID: 28927692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]